This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Maven: Firing on Bernanke's Targets

(Editor's note: To access some of these stories, registration or a subscription may be required. Please check the individual links for the site's policy.)

Federal Reserve Chairman Ben Bernanke does not have foot-in-mouth disease, The Wall Street Journal would have us think this morning. Nor is he a bright academic who is adjusting from his initial befuddlement at how, as Fed chair, his words are heard, weighed and analyzed by an entire world, not just a roomful of post-pubescents.

Rather, the Journal pontificates in pure apologist mode, when Bernanke took over from Alan Greenspan in February, he made some strategic changes that were "subtle but significant."

Will someone please remove this bazooka from The Business Press Maven's mouth before he pulls the trigger? Well maybe, in debunking Page One articles like this that have the capacity to confuse investors, I do have something to live for.

The story relies heavily on Mark Gertler, a New York University economist and close Bernanke friend, which means the notions Gertler was slinging could have been preapproved (if not prescribed) by Big Old Ben himself. Its basic gist was encapsulated in the headline: "The New Fed Chairman Hopes to Downplay Impact of His Words" and this line: "The new chairman is trying to depersonalize the Fed by making its decision-making more democratic and easier to understand."

He is going to accomplish this, we are then told, by talking less and, instead, publishing clear forecasts and goals on everything from growth to ... inflation.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
EAGL $12.00 3.00%
DG $74.42 0.00%
AAPL $124.75 0.00%
FB $80.78 0.00%
GOOG $524.05 0.00%

Markets

DOW 17,826.30 -279.47 -1.54%
S&P 500 2,081.18 -23.81 -1.13%
NASDAQ 4,931.8150 -75.9760 -1.52%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs